12:00 AM
 | 
Jan 03, 2011
 |  BC Week In Review  |  Clinical News  |  Clinical Status

Crolibulin: Phase I/II started

The National Cancer Institute began an open-label, U.S. Phase I/II trial in up to 70 patients. The dose-escalation Phase I portion of the trial will...

Read the full 115 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >